Monitoring Plan for Adrenal Insufficiency
Patients with adrenal insufficiency should be monitored by an endocrinologist at least annually, with clinical assessment for signs of over- and under-replacement, routine measurement of serum sodium and potassium, blood pressure monitoring, and annual screening for associated autoimmune conditions. 1
Frequency of Follow-Up Visits
- Adults and children: At least annually with an endocrinologist or healthcare provider with endocrine expertise 1
- Infants: Every 3-4 months 1
- More frequent visits are warranted if the patient has experienced recent adrenal crises or has ongoing problems with dose optimization 1
Clinical Monitoring at Each Visit
The monitoring of replacement therapy is primarily clinical rather than laboratory-based 1. At each visit, assess:
Glucocorticoid Replacement Assessment
- Weight stability (weight gain suggests over-replacement; weight loss suggests under-replacement)
- Pigmentation (most patients attain normal pigmentation on sufficient therapy) 1
- Symptoms of under-replacement: fatigue, weakness, anorexia, weight loss, salt craving
- Symptoms of over-replacement: weight gain, cushingoid features, metabolic complications
- Quality of life assessment: family relations, professional duties, self-esteem 1
- History of any adrenal crises since last visit 1
Mineralocorticoid Replacement Assessment (Primary AI Only)
- Blood pressure measurement (should be normal; orthostatic hypotension indicates insufficient mineralocorticoid or low salt intake) 1, 2
- Postural blood pressure to detect orthostatic changes 2
- Salt craving (suggests under-replacement) 2
Laboratory Monitoring
Routine Tests at Each Visit
- Serum sodium and potassium 1
- Plasma renin activity (PRA) for mineralocorticoid monitoring - aim for upper normal range 1, 2
Optional Laboratory Tests
- Cortisol measurement is not recommended for routine monitoring of glucocorticoid replacement, but can be useful to assess therapy adequacy in specific situations 1
Screening for Associated Conditions
Annual screening for autoimmune diseases is recommended in patients with primary adrenal insufficiency of autoimmune origin (or when autoimmune origin has not been excluded) 1:
- Thyroid disease (TSH, thyroid antibodies)
- Type 1 diabetes mellitus (glucose, HbA1c)
- Premature ovarian failure (in women of reproductive age)
- Celiac disease (tissue transglutaminase antibodies)
- Autoimmune gastritis with vitamin B12 deficiency (B12 levels, parietal cell antibodies) 1
Patient Education - Critical Component
Patient education must be reinforced at every visit 1. This is not optional but essential for preventing adrenal crisis:
Sick Day Management Education
- Sick day rule 1: Double the routine oral glucocorticoid dose when experiencing fever, illness requiring bed rest, infections requiring antibiotics, or before minor outpatient procedures 1
- Sick day rule 2: Inject 100 mg hydrocortisone IM/IV/SC for severe illness, trauma, persistent vomiting, fasting for procedures, or surgical intervention 1
Emergency Preparedness
Verify at each visit that the patient has:
- Steroid emergency card (check availability and that it's up to date) 1
- Medical alert bracelet or necklace stating "Adrenal insufficiency – needs steroids!" 1
- Hydrocortisone emergency injection kit (100 mg vials, syringes, needles) 1
- Sufficient supply of hydrocortisone and fludrocortisone accounting for sick days 1
- Emergency contact information for endocrine specialist team 1
Skills Assessment
Confirm the patient can:
- Identify situations requiring dose adjustment
- Recognize early signs of adrenal crisis
- Self-administer parenteral hydrocortisone 1, 3
- Understand when to seek emergency care 3
Special Populations
Adolescent Transition
The transition period between adolescence and adulthood represents added risk of breakdown in monitoring and requires particular attention with coordination between pediatric and adult medical teams 3.
Pregnancy
More frequent monitoring is needed during pregnancy, with dose adjustments of fludrocortisone to compensate for anti-mineralocorticoid activity of progesterone 2.
Common Pitfalls to Avoid
- Do not rely solely on laboratory values - clinical assessment is paramount 1
- Do not assume stable patients don't need annual visits - education reinforcement is critical 1
- Do not forget to check emergency supplies at each visit - many crises occur due to lack of preparedness 1
- Do not overlook screening for autoimmune conditions - these significantly impact morbidity 1
- Beware of mild hypovolemia - current mineralocorticoid replacement regimens may be inadequate in some patients 2, 4